No robust conclusions to be drawn from clinical trials in the absence of an adequate control group.
Ekberg
Henrik
H
Lund University, Malmo, Sweden. Henrik.ekberg@med.lu.se
Meier-Kriesche
Herwig-Ulf
HU
D016572:Cyclosporine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D000068338:Everolimus; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D015337:Multicenter Studies as Topic / Q000592:standards*; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012016:Reference Values; D015203:Reproducibility of Results; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D020123:Sirolimus